View of A Randomized, Double Blind, Placebo Controlled, Single Centric, 2 Arm Clinical Trial to Assess the Efficacy and Safety of Amrith Noni D Plus in Patients with Type II Diabetes Mellitus who are on OHA.

Return to Article Details A Randomized, Double Blind, Placebo Controlled, Single Centric, 2 Arm Clinical Trial to Assess the Efficacy and Safety of Amrith Noni D Plus in Patients with Type II Diabetes Mellitus who are on OHA. Download Download PDF